Evotec SE (EVO) Consolidated Net Income (2009 - 2025)
Evotec SE (EVO) reported Consolidated Net Income of -$120.4 million for Q4 2025, up 42.5% on a YoY basis from -$84.5 million in Q4 2024, and down 240274.03% sequentially from -$50074.1 in Q3 2025.
Evotec SE (EVO) Consolidated Net Income (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Consolidated Net Income data on file, last reported at -$120.4 million in Q4 2025.
- For the quarter ending Q4 2025, Consolidated Net Income rose 42.5% year-over-year to -$120.4 million; the trailing twelve-month figure through Mar 2026 stood at -$120.4 million (up 42.49% YoY), and the FY2025 full-year result was -$120.5 million, up 42.49% from the prior year.
- Consolidated Net Income declined to -$120.4 million in Q4 2025, from -$50074.1 in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $246.3 million in Q4 2021 to a low of -$209.3 million in Q4 2024.
- A 5-year average of -$23.5 million and a median of -$22125.4 in 2022 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income soared 8771.52% in 2021 and plunged 361.5% in 2024, its largest moves.
- Tracing EVO's Consolidated Net Income over 5 years: stood at $246.3 million in 2021, then sank by 172.83% to -$179.3 million in 2022, then surged by 49.68% to -$90.2 million in 2023, then sank by 131.96% to -$209.3 million in 2024, then surged by 42.5% to -$120.4 million in 2025.
- Business Quant data shows EVO's Consolidated Net Income at -$120.4 million in Q4 2025, -$50074.1 in Q3 2025, and -$209.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -120.37 Mn |
| Sep 30, 2025 | -50,074.14 |
| Dec 31, 2024 | -209.31 Mn |
| Sep 30, 2024 | -59,430.15 |
| Dec 31, 2023 | -90.24 Mn |
| Sep 30, 2023 | 22,726.50 |
| Jun 30, 2023 | -13,888.14 |
| Dec 31, 2022 | -179.34 Mn |
| Sep 30, 2022 | 39,779.45 |
| Jun 30, 2022 | -22,125.42 |
| Mar 31, 2022 | -72,868.90 |
| Dec 31, 2021 | 246.25 Mn |
| Sep 30, 2021 | 160,102.41 |
| Jun 30, 2021 | 73,489.46 |
| Mar 31, 2021 | 68,554.02 |
| Dec 31, 2020 | 7.47 Mn |
| Sep 30, 2020 | 1,804.68 |
| Dec 31, 2019 | 41.30 Mn |
| Sep 30, 2010 | 1,282.23 |
| Jun 30, 2010 | 2,369.92 |